Key facts
- This page summarizes Michael Vander Hoek's Form 4 filing for Shuttle Pharmaceuticals Holdings, Inc. (SHPH).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 08 Mar 2024, 18:18.
Michael Vander Hoek - 08 Mar 2024 Form 4 Insider Report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- SHPH
- Reported as of
- 08 Mar 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Mar 2024, 18:18:00 UTC
- Prior SEC filing
- 30 Dec 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Vander Hoek
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael Vander Hoek filed Form 4 for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) on 08 Mar 2024.
Change
- Previous filing in this sequence was filed on 30 Dec 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SHPH
transaction
COMMON STOCK
Award
- Transaction value
- $0
- Shares
- +100,000
- Change %
- +2596%
- Price
- $0.000000
- Shares after
- 103,852
- Date
- 08 Mar 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.